These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21366550)

  • 21. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
    Chen SR; Pan HL
    Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to target kyotorphin analogues to the brain.
    Chen P; Bodor N; Wu WM; Prokai L
    J Med Chem; 1998 Sep; 41(20):3773-81. PubMed ID: 9748352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal transport and metabolism of glucose-conjugated kyotorphin and cyclic kyotorphin: metabolic degradation is crucial to intestinal absorption of peptide drugs.
    Mizuma T; Koyanagi A; Awazu S
    Biochim Biophys Acta; 2000 Jun; 1475(1):90-8. PubMed ID: 10806343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects.
    Wang Z; Xu B; Jiang C; Zhang T; Zhang M; Li N; Zhang Q; Xu K; Chen D; Xiao J; Fang Q
    J Pain; 2020; 21(3-4):477-493. PubMed ID: 31521796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The spinal antinociceptive effect of FR140423 is mediated through kyotorphin receptors.
    Ochi T; Motoyama Y; Goto T
    Life Sci; 2000; 66(23):2239-45. PubMed ID: 10855944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential analgesic effects of a mu-opioid peptide, [Dmt(1)]DALDA, and morphine.
    Shimoyama M; Szeto HH; Schiller PW; Tagaito Y; Tokairin H; Eun Cm; Shimoyama N
    Pharmacology; 2009; 83(1):33-7. PubMed ID: 18987489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moderate protective effect of Kyotorphin against the late consequences of intracerebroventricular streptozotocin model of Alzheimer's disease.
    Angelova H; Pechlivanova D; Krumova E; Miteva-Staleva J; Kostadinova N; Dzhambazova E; Landzhov B
    Amino Acids; 2019 Nov; 51(10-12):1501-1513. PubMed ID: 31520285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid and adjuvant analgesics: compared and contrasted.
    Khan MI; Walsh D; Brito-Dellan N
    Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia.
    Zhang R; Xu B; Zhang Q; Chen D; Zhang M; Zhao G; Xu K; Xiao J; Zhu H; Niu J; Li N; Fang Q
    Eur J Pharmacol; 2020 Aug; 880():173169. PubMed ID: 32416184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Neuroprotective Action of Amidated-Kyotorphin on Amyloid β Peptide-Induced Alzheimer's Disease Pathophysiology.
    Belo RF; Martins MLF; Shvachiy L; Costa-Coelho T; de Almeida-Borlido C; Fonseca-Gomes J; Neves V; Vicente Miranda H; Outeiro TF; Coelho JE; Xapelli S; Valente CA; Heras M; Bardaji E; Castanho MARB; Diógenes MJ; Sebastião AM
    Front Pharmacol; 2020; 11():985. PubMed ID: 32733240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The orexigenic effect of kyotorphin in chicks involves hypothalamus and brainstem activity and opioid receptors.
    Webster RI; Newmyer BA; Furuse M; Gilbert ER; Cline MA
    Neuropeptides; 2013 Jun; 47(3):193-8. PubMed ID: 23261360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental study of antinociceptive potency of dipeptide GB-115 during chemical and thermal stimulation.
    Kolik LG; Zhukov VN; Gudasheva TA; Seredenin SB
    Bull Exp Biol Med; 2012 Aug; 153(4):468-71. PubMed ID: 22977846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of D-arginine on antinociception induced by kyotorphin, Tyr-cav, L-cav and Tyr(Cl2)-cav in rats.
    Bocheva A
    Methods Find Exp Clin Pharmacol; 2004 Jun; 26(5):335-8. PubMed ID: 15319811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opiate-like peptides. Part IV. Kyotorphin and its analogues: synthesis and analgesic activity.
    Rolka K; Oslislok E; Krupa J; Kruszyński M; Baran L; Przegaliński E; Kupryszewski G
    Pol J Pharmacol Pharm; 1983; 35(6):473-80. PubMed ID: 6677896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
    Front Immunol; 2020; 11():615327. PubMed ID: 33408720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal RGS4 inhibitor, CCG50014, reduces nociceptive responses and enhances opioid-mediated analgesic effects in the mouse formalin test.
    Yoon SY; Woo J; Park JO; Choi EJ; Shin HS; Roh DH; Kim KS
    Anesth Analg; 2015 Mar; 120(3):671-677. PubMed ID: 25695583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
    Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
    J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
    Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
    Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the antinociceptive dipeptide L-tyrosine-L-arginine (kyotorphin) on the motivation, anxiety, and memory in rats.
    Angelova H; Krumova E; Dzhambazova E; Pechlivanova D
    Folia Med (Plovdiv); 2021 Apr; 63(2):189-196. PubMed ID: 33932008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain.
    Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP
    Eur J Pharmacol; 2010 Dec; 648(1-3):87-94. PubMed ID: 20828549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.